)
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
It is working on a plan to secure supplies for next two-three quarters
Maruti Suzuki sees passenger vehicle growth returning to 7% CAGR by FY27, with small car sales projected to rise 10% as GST cuts, tax relief and lower EMIs boost demand
Automakers including M&M, Tata Motors and Hyundai confirm vehicles made since 2023 are safe on E20 fuel, countering fears as Gadkari calls social media criticism politically driven
Overall amount paid by dealers in compensation cess is estimated to be in excess of Rs 4000 crore
Despite China's assurance, Indian automakers are yet to get rare earth supplies, deepening EV and auto component uncertainty
OEMs already favour retail market share based data to forecast production and dispatches
Maruti's Alto could see a price drop by ₹40,000-50,000, while the entry-level Wagon R may see reductions between ₹60,000 and ₹67,000
Citroen eyes stronger India play with Basalt X SUV, aiming to double market share in three months while exports from Thiruvallur are projected to cross 10,000 units in FY26
Auto dealers expect a boost in the second half of FY25 following GST cuts on vehicles and parts, which aim to improve affordability
GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss
Several Indian companies have similar safeguards in place, though few were forthcoming about their policies when contacted
Mercedes-Benz India MD & CEO Santosh Iyer says GST rationalisation will boost festive sales, with buyers set to gain 5-8% price benefit
GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes
The Union Health Ministry has proposed amendments to NDCT Rules 2019 to reduce test licence timelines from 90 to 45 days and ease approvals for BA/BE studies
UCPMPD 2024 boosts transparency and ethics, but smaller firms may struggle with higher costs and reporting demands
Analysts say Indian pharma firms will increase focus on non-US exports and the domestic market as US tariff threats persist, with firms exploring offshore manufacturing options
CEAT expects a 10-15% topline boost after acquiring Michelin's Camso compact construction line in a $225 mn deal, gaining Sri Lanka plants and global brand rights
The investment is aimed at expanding manufacturing capacity for off-highway tyres (OHT) and tracks at the Midigama and Kotugoda facilities
VAHAN data shows 3% m-o-m drop in retail auto sales; EV market hopes hold up
Maharashtra and UP lead India's Q1FY26 automobile sales across passenger, two-wheeler, three-wheeler and CV segments, as per SIAM data